Search / Trial NCT06236035

Intraoperative Analgesia Based on ANI

Launched by ZONGULDAK BULENT ECEVIT UNIVERSITY · Jan 31, 2024

Trial Information

Current as of October 03, 2024

Completed

Keywords

Analgesia Nociception Index Opioid Consumption Pain Management

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1.18-75 years old, 2.ASA I-II-III risk group 3.undergo knee operation under general anesthesia 4. Patients with preoperative femoral nerve block 5. Patients whose informed consent was read and consent was obtained from them and their guardian
  • Exclusion Criteria:
  • 1. Those who do not want to participate in the study,
  • 2. ASA IV-V patients
  • 3. Those with central or autonomic nervous system disease

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Zonguldak, Kozlu, Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0